{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:52:07Z","timestamp":1772891527684,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.colsurfb.2024.114253","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T21:12:43Z","timestamp":1726607563000},"page":"114253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Old drugs, new tricks: Delivering pitavastatin-loaded nanostructured lipid carriers for glioblastoma treatment"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-7324","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Basso","sequence":"first","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-548X","authenticated-orcid":false,"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"Supplement_5","key":"10.1016\/j.colsurfb.2024.114253_bib1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.colsurfb.2024.114253_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114253_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijpharm.2017.07.056","article-title":"Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches","volume":"531","author":"Miranda","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114253_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: from bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2024.114253_bib5","series-title":"Drug Repurposing in Cancer Therapy","first-page":"353","article-title":"Nanotechnological approaches in cancer: the role of celecoxib and disulfiram","author":"Basso","year":"2020"},{"key":"10.1016\/j.colsurfb.2024.114253_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101127","article-title":"A comprehensive review on the lipid and pleiotropic effects of pitavastatin","volume":"84","author":"Sahebkar","year":"2021","journal-title":"Prog. Lipid Res."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114253_bib7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bjc.2014.431","article-title":"In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells","volume":"111","author":"Jiang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114253_bib8","first-page":"1","article-title":"Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs","volume":"12","author":"Jiang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.colsurfb.2024.114253_bib9","doi-asserted-by":"crossref","unstructured":"H. Muller, R.R. Shegokar, C.M. Keck20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Current drug discovery technologies, 8(3): p. 207-227.2011.","DOI":"10.2174\/157016311796799062"},{"issue":"1-2","key":"10.1016\/j.colsurfb.2024.114253_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114253_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-662-47862-2_11","article-title":"Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles","author":"M\u00fcller","year":"2016","journal-title":"Percutaneous Penetration Enhanc. Chem. Methods Penetration Enhanc.: Nanocarriers"},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114253_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114253_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/biom12020223","article-title":"A stepwise framework for the systematic development of lipid nanoparticles","volume":"12","author":"Basso","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.colsurfb.2024.114253_bib14","series-title":"Properties of polymers: their correlation with chemical structure; their numerical estimation and prediction from additive group contributions","author":"Van Krevelen","year":"2009"},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114253_bib15","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i1.20","article-title":"Optimizing drug delivery systems using systematic\" design of experiments.\" Part I: fundamental aspects","volume":"22","author":"Singh","year":"2005","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"8","key":"10.1016\/j.colsurfb.2024.114253_bib16","first-page":"577","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate","volume":"60","author":"\u00dcner","year":"2005","journal-title":"Die Pharm. - Int. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2024.114253_bib17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/molecules28041833","article-title":"Development of computational in silico model for nano lipid carrier formulation of curcumin","volume":"28","author":"Albasri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.colsurfb.2024.114253_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.colsurfb.2024.114253_bib19","doi-asserted-by":"crossref","unstructured":"Bruschi, M.L., Mathematical models of drug release. 2015, Woodhead Publishing Cambridge, UK. p. 63-86.","DOI":"10.1016\/B978-0-08-100092-2.00005-9"},{"key":"10.1016\/j.colsurfb.2024.114253_bib20","unstructured":"International Conference on Harmonization, Pharmaceutical Development Q8 R2, ICH, Editor. 2009: London. p. 1-28."},{"issue":"21","key":"10.1016\/j.colsurfb.2024.114253_bib21","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood\u2013brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2024.114253_bib22","series-title":"Nanostructures for novel therapy","first-page":"811","article-title":"Role of excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs\/NLCs)","author":"Doktorovova","year":"2017"},{"key":"10.1016\/j.colsurfb.2024.114253_bib23","unstructured":"Rowe, R.C., P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients. 2009: Libros Digitales-Pharmaceutical Press."},{"key":"10.1016\/j.colsurfb.2024.114253_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02976689","article-title":"Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats","volume":"26","author":"Zhang","year":"2003","journal-title":"Arch. Pharmacal Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114253_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2133\/dmpk.DMPK-10-RG-073","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein\/multidrug resistance 1","volume":"26","author":"Shirasaka","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114253_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2010.12.024","article-title":"The size of solid lipid nanoparticles: an interpretation from experimental design","volume":"84","author":"Vitorino","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2024.114253_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1010031605547","article-title":"Measurement of the density of polymeric nanoparticulate drug carriers by isopycnic centrifugation","volume":"1","author":"Vauthier","year":"1999","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.colsurfb.2024.114253_bib28","unstructured":"Harmonization, I.Co, Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances Q6A, I.C.H., Editor. 1999: London. p. 1-35."},{"issue":"1","key":"10.1016\/j.colsurfb.2024.114253_bib29","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/10717544.2018.1529209","article-title":"Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy","volume":"25","author":"Cirri","year":"2018","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114253_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10973-009-0127-z","article-title":"Studies on crystallinity state of puerarin loaded solid lipid nanoparticles prepared by double emulsion method","volume":"99","author":"Li","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"issue":"2","key":"10.1016\/j.colsurfb.2024.114253_bib31","article-title":"Lipid based solid self-emulsifying delivery system of pitavastatin calcium: development and characterization","volume":"14","author":"Moreshwar","year":"2022","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"issue":"6","key":"10.1016\/j.colsurfb.2024.114253_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.addr.2007.04.013","article-title":"Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.","volume":"59","author":"Bunjes","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2024.114253_bib33","unstructured":"Paul Adrian, V.D.S., et al., Crystalline forms of pitavastatin calcium, Wipo, Editor. 2004."},{"issue":"9","key":"10.1016\/j.colsurfb.2024.114253_bib34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/pharmaceutics12090820","article-title":"Rheology by design: a regulatory tutorial for analytical method validation","volume":"12","author":"Sim\u00f5es","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.colsurfb.2024.114253_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524005125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524005125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:09:44Z","timestamp":1732896584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776524005125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S0927776524005125"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114253","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Old drugs, new tricks: Delivering pitavastatin-loaded nanostructured lipid carriers for glioblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114253"}}